Astex Pharma: Will the Japanese profit from the USA/UK small molecules?

Astex will make a great case study.

Who are the equity winners in the Astex story?  It is quite fascinating.  It is very different from the entrepreneurs who start a company  on a kitchen table with low overheads and low salaries trying to build value  in the business and keeping as much equity as possible.  This is just not possible in the bio world.  Big money is required to develop drugs and it leaves the founders struggling to keep much equity in the company.  They only come good through options which “vest” on sale.  Well that is what I learn from a quick look through of the public data.  It is quite a story.

It goes like this, starting in 1999:

- take two Cambridge professors, Prof Abell and Prof Sir Tom Blundell

- add commercial skills gained at GSK, Dr Harren Jhoti

- raise nearly £100million of VC funds (perhaps the VCs put the team together) leaving the founders with tiny shareholdings but some with high salaries

- use small molecules and high throughput robots to identify potential drugs

- partner with pharma companies to develop five potential drugs

- in 2011, “merge” with a quoted drug company listed in New York which has strong commercial skills and plenty of cash

- close down the USA laboratory

- in 2013, sell to a Japanese pharma company and cash in the options.

The Japanese company, Otsuka Pharmaceuticals,  bought Astex Pharmaceuticals for $800million in October 2013.  Who will be the winner?  Is this another story of academic research in the UK being sold before a great company has been built?  Can you build a great pharma company from scratch?  Is it really for entrepreneurs?

 

According to the University of Cambridge website, the story goes back to 1999 when Prof Abell and Prof Sir Tom Blundell combined with Dr Harren Jhoti from GlaxoSmithKline (with partial seed funding from the University of Cambridge) to form Astex. The two professors had developed fragment based drug discovery.  It is easier to use small fragments and fast processing techniques to work out which is active and then you can design your drug (I think).  I guess that this sounds easy but needs great brains to realise and then make happen.

In 2011, Astex merged with Supergen Inc of Dublin, California.  Supergen was a quoted Delaware company – it is always Delaware!  By the time of the merger, both companies has raised some $100million of funds.  It was more a merger of equals.  From a quick read through all the papers, the research labs near Dublin were closed and the new company concentrated on the work in Cambridge where some 80 people were employed.  The companies ran up some $350 million of losses but revenue from partnership with the major drug companies were covering running costs.  It appears that the owners, (VCs?) of Astex flipped the company into a Delaware quoted company bringing along the science with Supergen providing the quote and the commercial strength with their James Manuso becoming Chair and CEO.  It is a great model and has happened to many University of Cambridge spin-outs.

Of course, running a fast moving company in such a competitive and fast moving world as pharma needs top talent.  The directors were well paid, with top people earning hundreds of thousands of pounds per year.  The details are available on line as for all quoted companies for those with time to search.

The holdings of the directors are available on line and make interesting reading.

What happened to the staff?  Did they have an option scheme?

What happened to the two founding professors? To CE?

Has the UK lost out on building a great UK company?

Links:

Astex annula reports: http://investor.astx.com/annuals.cfm

Astex board: http://investor.astx.com/committees.cfm

Astex SEC filings         Pharma Television

Astex pipeline             Astex Scientific Advisory Board      University of Cambridge press release on sale

Compensation form              Options and shares               Astex 2012 Annual Report

 

 

 

 

1 Comment

  1. maymay wrote
    at 10:04 am - 28th May 2014 Permalink

    The first couple preferred to a booming enterprise within your personally own commercially aware restaurant or possibly rolex replica uk. Still, which usually most likely practical specifically those that which have only just initiated maturing and additionally cannot really only just eliminate his or her self a result of the breathing space limitations. Collins Lane Home business Coronary heart has the opportunity to succeed within the polite and additionally high quality natural world. Individuals deal with the necessary home business really needs and additionally standards, subsequently permitting you to succeed with very little cartier replica. Most of the factories and additionally sustain service plan makes investment and additionally makes sense to consider maturing and additionally maintaining the market. Long lasting will want is normally, it’s always simply joined in and additionally with very little chanel outlet. Individuals deal with the necessary really needs and additionally completely understand any necessitie. They provide for you to ultimately succeed within the high quality and additionally rewarding natural world. Individuals lease or possibly rent out work as well as to make sure you giant vendors still produce same weightage to make sure you reduced vendors likewise. Most of the well maintained office spaces ordinarily are not any enquiry just for Melbourne sole still experience systems just for other sorts of financing towns and cities that include Sydney, Brisbane, Adelaide and additionally Perth. Collins Lane Home business rolex replica watches comes with sunk intensively for solutions. This approach establishes particularly important considering that it raises the economy about succeed issuing out an easier conclusion. There may professionalism by having a polite come near. All the role-specific office personnel is constantly in that respect there to fulfill what you want and additionally fake rolex daytona watches. All the supply for the Business Bedrooms, national gathering sites and additionally Get together sites adds something to any collaborative snapshot together with changes your business interest process.

Post a Comment

Your email is never published nor shared. Required fields are marked *